Creative Biolabs provides world leading custom CellRapeutics™ Chimeric Antigen Receptor (CAR) construction service. With the most advanced techniques and years of experiences, we have established a solid platform for CAR production which can greatly accelerate your project progress.
The types of cancer which can be targeted by CellRapeutics™ CAR-T cells or CAR-NK cells include: Leukemia and Lymphoma, Carcinoma (breast cancer, prostate cancer, colorectal cancer, lung malignancy, adenocarcinomas, cervical carcinoma, melanoma, renal cell carcinoma), Sarcoma (advanced osteosarcoma, rhabdomyosarcoma), Blastoma (glioblastoma, medulloblastoma, neuroblastoma), Germ cell tumor (ovarian cancer), other cancers and viral infection.
Shi H, Sun M, Liu L, Wang Z. Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects. Mol Cancer. 2014 Sep 21;13:219.
Cancer is a common name which includes a group of more than 100 kinds of diseases. It starts as a result of fast and uncontrolled cell proliferation with spreading to other tissues of the body. Adoptive immunotherapy with CAR-modified T cells has become a very promising strategy in cancer treatment, resulting in extraordinary breakthrough in this field. CAR is a recombinant protein including a scFv from an antigen-specific mAb which is designed for redirecting T-cell’s activating response. Adoptive transfer of CAR modified T cells has been developed by researchers for treating various types of cancer. In Creative Biolabs, we can provide CARs targetting various antigens such as CD19, CD20, according to your different immunology research purposes.
Our scientists with extensive experience have developed CellRapeutics™ Chimeric Antigen Receptor (CAR) platform targeting cancer antigens presented on numerous types of cancer cells. As a leading custom service provider with the best performance, we guarantee that our scientists can offer diverse sophisticated strategies for CAR products construction just in order to meet all your requirements.
Copyright © 2007 - 2017 Creative Biolabs. All Rights Reserved